Please login or register first to view this content.
Allergic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies
Orladeyo Now Available for Hereditary Angioedema
Novel Budesonide Oral Suspension Gets Priority Review for Eosinophilic Esophagitis
FDA Approves Orladeyo to Prevent Hereditary Angioedema Attacks
Hormonal Contraceptives Linked to Decline in Asthma Exacerbation
Crisaborole Safe, Efficacious in Atopic Dermatitis, With or Without Allergic Rhinitis
Flare Size in Skin Prick Test May Predict Oral Food Challenge Outcomes
Dupilumab Demonstrates Long-Term Efficacy, Safety for Improving Asthma Control
Omalizumab Shows Continued Efficacy for Chronic Rhinosinusitis With Nasal Polyps
Osteoarthritis, NSAID Allergy Are Risk Factors for Opioid Use Disorder
Benralizumab Achieves Clinically Meaningful Improvements in Asthma, Nasal Polyposis
Atopic Dermatitis Does Not Appear to Affect COVID-19 Severity
Corticosteroid Exposure Affects Bone Health in Asthma Patients
Assessing the Effect of 2019 GINA Classification Changes in Patients With Asthma
Dupilumab Associated With Reduced Severe Outpatient Asthma Exacerbation Rates
Early Introduction of Gluten Linked to Decline in Celiac Disease
OTC Medicines Containing “Clean” Inactive Ingredients Launched
Dupilumab Gets Breakthrough Therapy Status for Eosinophilic Esophagitis
